Non-Small Cell Lung Cancer: Biomarker Testing and Treatment Trends

Listen Now

Topics Covered

• Non-Small Cell Lung Cancer Overview in the Context of COVID, Seasonal Flu & RSV
• Definition of Genomics & Biomarker Testing
• The Difference Between Genomics & Genetics
• The Role of Biomarker Testing in the Treatment of Non-Small Cell Lung Cancer
• Specific Examples of How Biomarker Testing May Inform Treatment Decisions
• Precision Medicine & Non-Small Cell Lung Cancer
• Current Research in Genomics & Non-Small Cell Lung Cancer
• Liquid Biopsies
• The Role of the Pathologist
• Reviewing Your Biomarker Testing with Your Health Care Team
• Key Questions to Ask Your Health Care Team About Biomarker Testing & Its Benefits for Your Treatment Choices
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Care & Discussion of OpenNotes
• Questions to Ask Our Panel of Experts

Our Panel of Experts

Mark G. Kris, MD

William and Joy Ruane Chair in Thoracic Oncology, Attending Physician, Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College

Joshua K. Sabari, MD

Attending Physician, Thoracic Medical Oncology, Assistant Professor of Medicine, NYU Langone Health, Perlmutter Cancer Center

Robert Hsu, MD

Assistant Professor of Clinical Medicine, Division of Medical Oncology, USC Norris Comprehensive Cancer Center

Nikki Martin, MA

Senior Director of Precision Medicine Initiatives, LUNGevity Foundation®

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on December 10, 2024.